Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 23:00 save search
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
Published: 2024-04-16 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
management company cell nurown trial therapeutics
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
Published: 2024-04-15 (Crawled : 23:00) - biospace.com/
APVO | $0.6827 -7.27% -7.84% 570K
|
Health Technology
|
| O: -4.09%
H: 4.5%
C: -3.39%
million offering therapeutics
NeuroSense Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement
Published: 2024-04-10 (Crawled : 23:00) - neurosense.investorroom.com
NRSN | News | $1.33 -2.21% -2.26% 130K
|
|
| O: -6.02%
H: 0.0%
C: 0.0%
million direct offering
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
Published: 2024-04-09 (Crawled : 23:00) - alteritytherapeutics.com
ATHE | $2.33 9.39% 8.58% 170K
|
Health Technology
|
| O: 1.05%
H: 22.28%
C: 13.47%
ath434 drug congress world therapeutics usa
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 23:00) - biospace.com/
STOK | $11.64 3.47% 3.35% 1.5M
|
Health Technology
|
| O: 1.83%
H: 6.44%
C: -6.74%
conference therapeutics
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
Published: 2024-03-26 (Crawled : 23:00) - prnewswire.com
INO | $10.1 -2.6% -2.67% 250K
|
Health Technology
|
| O: 0.0%
H: 6.06%
C: 5.25%
therapeutics
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-25 (Crawled : 23:00) - biospace.com/
STOK | $11.64 3.47% 3.35% 1.5M
|
Health Technology
|
| O: -0.16%
H: 8.11%
C: 3.34%
year therapeutics financial results
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome
Published: 2024-03-25 (Crawled : 23:00) - biospace.com/
STOK | $11.64 3.47% 3.35% 1.5M
|
Health Technology
|
| O: -0.16%
H: 8.11%
C: 3.34%
stk-001 first treatment therapeutics potential
S-4 – FIRSTSUN CAPITAL BANCORP (0001709442) (Filer)
Published: 2024-03-08 (Crawled : 23:00) - spacfeed.com
PSTV | News | $1.55 -4.91% -5.16% 8.4K
|
Health Technology
| Email alert
Add to watchlist
FSUN | $34.5 -3.2% 3.9K
|
n/a
| Email alert
Add to watchlist
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.84%
H: 0.28%
C: -5.25%
year therapeutics financial results
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
ERNA | $1.8 -8.16% -8.89% 12K
|
Information
|
| O: 3.16%
H: 0.0%
C: -0.5%
LCTX | $1.1 -3.51% 0.0% 740K
|
Health Technology
|
| O: 1.77%
H: 0.0%
C: -1.74%
business year update cell therapeutics financial results
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 23:00) - globenewswire.com
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: -0.21%
H: 5.61%
C: 3.95%
association presentation cancer research meeting therapeutics
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 23:00) - globenewswire.com
IPSC | $2.98 -4.79% -5.03% 130K
|
Professional, Scientific, and T...
|
| O: 2.59%
H: 16.28%
C: 14.68%
six association cancer research meeting therapeutics
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery
Published: 2024-03-04 (Crawled : 23:00) - prnewswire.com
EYEN | $0.5897 8.68% 7.99% 770K
|
Health Technology
|
| O: -2.19%
H: 0.0%
C: -21.08%
fda ocular approval treatment pharmaceuticals therapeutics
PTC Therapeutics to Participate at Upcoming Investor Conferences
Published: 2024-02-27 (Crawled : 23:00) - prnewswire.com
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: -0.46%
H: 2.61%
C: 0.07%
therapeutics
Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-27 (Crawled : 23:00) - prnewswire.com
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 2.67%
H: 1.3%
C: -6.49%
management conference health care
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
Published: 2024-02-26 (Crawled : 23:00) - prnewswire.com
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 4.48%
H: 8.57%
C: 7.14%
financial results
The New England Journal of Medicine Publishes Positive Phase 3 RESPONSE Data of CymaBay's Seladelpar in Primary Biliary Cholangitis
Published: 2024-02-21 (Crawled : 23:00) - prnewswire.com
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 0.09%
H: 0.12%
C: -0.06%
positive response
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-20 (Crawled : 23:00) - biospace.com/
BCYC | $22.7 0.09% 0.09% 520K
|
Health Technology
|
| O: -1.78%
H: 4.75%
C: 2.67%
business year bicycle therapeutics financial results
Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth
Published: 2024-02-13 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -2.71%
H: 0.0%
C: 0.0%
ZTS | $150.88 0.88% -0.5% 3.6M
|
Health Technology
|
| O: 0.93%
H: 0.7%
C: -0.6%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.56%
H: 1.3%
C: 1.22%
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: -1.14%
H: 1.3%
C: 1.2%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.38%
H: 2.44%
C: 1.54%
ELAN | $13.31 -1.11% 0.0% 3.8M
|
Process Industries
|
| O: 1.53%
H: 1.16%
C: 0.82%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: -1.14%
H: 1.3%
C: 1.2%
PAHC | $12.575 -7.61% -8.23% 110K
|
Health Technology
|
| O: 1.32%
H: 4.7%
C: 4.09%
NEOG 4 | $12.375 0.53% 0.53% 2.5M
|
Health Technology
|
| O: -0.24%
H: 4.39%
C: 3.29%
management propel disease report animal global animals dermatological diagnostics therapeutics growth market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.